1. Pink Sheet
  2. >>R&D
  3. >>Clinical Trials

UK Plans Major Clinical Trial Legislation Revamp

Firms Told To 'Get Ready To Engage'

 
• By Ian Schofield

The head of the UK’s medicines regulator says plans will soon be released for ensuring the country remains a preferred location for conducting clinical trials.

Clinical trial
The UK is charting its own course in clinical trial regulation • Source: Alamy

The UK Medicines and Healthcare products Regulatory Agency is to launch a consultation on changes to the clinical trial legislation intended to streamline the approval and start-up of trials, increase the use of novel study designs, and put the patient at the heart of the trials landscape.

A key aim of the legislative changes will be fostering wider international collaboration and “interoperability” with a view to ensuring the UK remains a preferred site to carry out multinational clinical trials, the agency's chief executive June Raine told this year’s

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

UK Health Data Research Service Looks ‘Encouraging’ For Industry, But Implementation Details Will Be Key

 
• By Anabel Costa-Ferreira

Marcus Vass and Vladimir Murovec of international law firm Osborne Clarke tell the Pink Sheet what the government's planned HDRS might mean for industry, and how it compares with the European Health Data Space.

EU Health Data Space May Speed Up R&D Through Access To Multi-Omics & Clinical Record Data

 
• By Eliza Slawther

The European Health Data Space framework will allow companies to accelerate R&D processes and identify new molecular targets faster by facilitating centralized access to certain types of high-quality data, Finland’s Orion Pharma says.

What The EMA Can Teach HTA Bodies About Joint Clinical Assessments

 
• By Francesca Bruce

EU-level joint clinical assessments conducted under the Health Technology Assessment Regulation need to be more flexible when it comes to evidence requirements, according to experts speaking at a gene and cell therapy conference.

EU ‘Can’t Expect Industry To Give Up Proprietary Insights’ Under Health Data & Clinical Trials Regulations

 
• By Eliza Slawther

Both the EU Clinical Trials Regulation and the European Health Data Space Regulation have the potential to improve harmonization and be highly valuable for industry – but the importance of protecting company data will be paramount, a life sciences consultant says.

More from R&D